CORVALLIS, Ore., May 8, 2025 /PRNewswire/ -- Karma Biosciences announced today that it has applied for patent protection for two new drug formulations utilizing its proprietary excipient Zenergy™ .
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback